At the University of British Columbia, the Blakney Lab is focused on developing vaccines and therapies using self-amplifying ...

Biotechnology company Moderna (NASDAQ:MRNA) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 35.3% ...

Fabrice Gritti, consultant scientist at Waters Corporation, spoke to LCGC International about the history of slalom ...

Research published in the Journal of Neurochemistry has detailed the role of a protein, hnRNP A1, in the formation and ...

Moderna stock crumbled Thursday after the biotech company missed sales estimates for its two products, Spikevax and mResvia.

Moderna, the bloodied Covid-era prizefighter of the healthcare sector, stumbles toward its next earnings report on Thursday ...

Huntington’s disease slows the cell’s protein factory, causing production line jams & toxicity. A faulty blueprint & missing ...